A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cellsCourtney M. Tate(Eli Lilly (United States)), Louis F. Stancato(Indiana Biosciences Research Institute)Cell Death and DifferentiationApril 27, 201210.1038/cdd.2012.44Cited by 65SaveCiteExport RISWatch citationsRelated PapersLY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer|Oncotarget|2016|68A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology|PLoS ONE|2015|18